-
Mashup Score: 0‘We’ve come a long way’: Recent Sjögren’s research provides ‘more hope than ever before’ - 42 minute(s) ago
Research into Sjögren’s disease — both analyzing the condition itself and testing potential treatments — has come a long way in the past decade.“Fifteen years ago, we had no clinical trials, no pharma interest in Sjögren’s, and we were starting to see lupus trials fail one after the other,” Kathy M. Hammitt, vice president of medical and scientific affairs at
Source: www.healio.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 0
CHICAGO — An autologous point-of-care cell therapy for adults with ischemic HF with reduced ejection fraction was safe and may be beneficial for select candidates, though a pivotal study did not meet its primary efficacy outcome.New 2-year data from the CardiAMP-HF trial, presented at the American College of Cardiology Scientific Session, suggest that the first cardiac cell therapy
Source: www.healio.comCategories: General Medicine NewsTweet-
New 2-year data from CardiAMP-HF at #ACC25 suggest autologous cell therapy may show benefit for select people with ischemic #HFrEF, despite the trial not meeting its primary efficacy endpoint @HemOncToday https://t.co/HykP9q6tT2
-
-
Mashup Score: 2Mortality risk in patients with arthritis rises with comorbid COPD - 14 hour(s) ago
The risk for all-cause and cardiovascular disease mortality was heightened when adults had arthritis plus comorbid COPD, according to data published in Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation.“For clinicians, these findings underscore the importance of screening arthritis patients for COPD, especially given the heightened risk of mortality,” Chengfeng
Source: www.healio.comCategories: General Medicine News, PulmonologyTweet-
Published in Chronic Obstructive Pulmonary Diseases: Journal of the @COPDFoundation: The risk for all-cause and cardiovascular disease mortality was heightened📈 when adults had #arthritis plus comorbid #COPD. @HealioRheum https://t.co/WQwtxpJhEn
-
-
Mashup Score: 2
In patients with diabetes, semaglutide use was associated with an increased risk for nonarteritic anterior ischemic optic neuropathy, according to a study published in JAMA Ophthalmology.
Source: www.healio.comCategories: General Medicine News, OphthalmologyTweet-
Learn more about the increased risk for nonarteritic anterior ischemic optic neuropathy found with #semaglutide use in patients with #diabetes. Ophthalmologist Dr. Susan P. Mollan and endocrinologist Dr. Caroline M. Apovian offer their perspectives👇 https://t.co/AgsFqYIZ7l https://t.co/Rm0SraP08I
-
-
Mashup Score: 0FDA clears Leos laser system for glaucoma - 16 hour(s) ago
The FDA granted 510(k) clearance for Leos, a laser endoscopy ophthalmic system for a more intuitive laser endoscopic cyclophotocoagulation procedure, according to a press release from BVI Medical.
Source: www.healio.comCategories: General Medicine News, OphthalmologyTweet-
❗BREAKING❗ The #FDA granted 510(k) clearance for a laser endoscopy ophthalmic system for #glaucoma. Find out more: #OcularSurgeryNews https://t.co/NWERjDLKJj https://t.co/CBLVZPkDAv
-
-
Mashup Score: 7‘We’ve come a long way’: Recent Sjögren’s research provides ‘more hope than ever before’ - 17 hour(s) ago
Research into Sjögren’s disease — both analyzing the condition itself and testing potential treatments — has come a long way in the past decade.“Fifteen years ago, we had no clinical trials, no pharma interest in Sjögren’s, and we were starting to see lupus trials fail one after the other,” Kathy M. Hammitt, vice president of medical and scientific affairs at
Source: www.healio.comCategories: General Medicine News, RheumatologyTweet-
💡 “We urge #rheumatologists to look for Sjögren’s in all of their #autoimmune disease patients,” said Kathy Hammitt. @SjogrensOrg Check out our full Q&A for #Sjogrens Awareness Month 👇 https://t.co/1ETyLYzeUz
-
-
Mashup Score: 2Skin toxicities can persist for more than a year after immune checkpoint inhibitor therapy - 17 hour(s) ago
Cutaneous immune-related adverse events that develop after immune checkpoint inhibitor therapy become chronic in nearly one-quarter of cases, according to a research letter published in JAMA Dermatology.These chronic events often persist more than a year after immune checkpoint inhibitor (ICI) discontinuation, results showed.
Source: www.healio.comCategories: General Medicine NewsTweet-
💡Approximately 25% of cutaneous immune-related adverse events that develop after #ICI therapy become chronic, according to research in @JAMADerm. Healio spoke with a professor at @VUMCDiscoveries about the data. Read more at 🔗👇 https://t.co/ER6VTSFKER
-
-
Mashup Score: 4
Researchers are aiming to raise attention to the amount of waste generated with the use of diabetes devices, insulin and other treatment tools.In a small study published in Diabetes Care, 49 adults with diabetes who used a continuous glucose monitor, used an insulin pump or received at least three insulin injections per day tracked the type and amount of diabetes-related waste they threw out for
Source: www.healio.comCategories: General Medicine News, EndocrinologyTweet-
♻️Each person with #diabetes in the U.S. generates about 3 lbs of diabetes-related waste per month, according to data published in @DiabetesCareADA. Healio spoke with three authors of the study about diabetes-related waste. @DavidKlonoff https://t.co/897BZ499ak
-
-
Mashup Score: 0Evolution of surgical treatment of the disabled throwing shoulder - 18 hour(s) ago
The surgical treatment of the disabled throwing shoulder has rapidly evolved. Thanks to many mentors, especially W. Ben Kibler, MD, FACSM, and Thay Q. Lee, PhD, I am eager to share the insights I have gained during the last 3 decades. Before we embrace surgical steps, some basic truths regarding the biceps/superior labrum complex that have served me well are worthy of mention.
Source: www.healio.comCategories: General Medicine NewsTweet-
In this month’s Surgical Technique, @JohnDKellyIVMD, from @PennMedicine, discusses the evolution of surgical treatment of the disabled throwing shoulder. https://t.co/efCKgbWp7C
-
-
Mashup Score: 0RSV triples a person’s risk for death within 1 year, study shows - 20 hour(s) ago
VIENNA — After decades of fits and starts, scientists finally got the world’s first vaccines against respiratory syncytial virus across the finish line in 2023.
Source: www.healio.comCategories: General Medicine News, Infectious DiseaseTweet-
🤒 RSV-associated acute respiratory infection raises an adult’s risk for death within 1 year by 2.7 times, according to study findings presented at #ESCMIDGlobal. #IDtwitter #MEDtwitter https://t.co/gcAShrpE20
-
💡 “We urge #rheumatologists to look for Sjögren’s in all of their #autoimmune disease patients,” said Kathy Hammitt. @SjogrensOrg Check out our full Q&A for #Sjogrens Awareness Month 👇 https://t.co/1ETyLYzeUz